Carregant...
Eltrombopag use for refractory immune thrombocytopenia in pregnancy: A case report
BACKGROUND: Immune thrombocytopenic purpura (ITP) is a rare autoimmune disorder that involves platelet destruction in the spleen. Eltrombopag (Promacta®), a thrombopoietin agonist, has been used in non-pregnant patients to manage ITP, but few cases of its use in pregnancy have been reported. CASE PR...
Guardat en:
| Publicat a: | Case Rep Womens Health |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7788087/ https://ncbi.nlm.nih.gov/pubmed/33437657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.crwh.2020.e00281 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|